Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00611
|
|||||
Drug Name |
Istradefylline
|
|||||
Synonyms |
(E)-8-(3,4-Dimethoxystyryl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione; (E)-8-(3,4-Dimethoxystyryl)-1,3-diethyl-7-methylxanthine; 8-((1E)-2-(3,4-Dimethoxyphenyl)ethenyl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione; 8-(2-(3,4-dimethoxyphenyl)ethenyl)-1,3-diethyl-3,7-dihydro-7-methyl-1H-purine-2,6-dione; 8-[(E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-7-methylpurine-2,6-dione; Istradefylline; Istradefylline (JAN/USAN/INN); Istradefylline [USAN:INN]; KW 6002
|
|||||
Drug Type |
Small molecular drug
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C20H24N4O4
|
|||||
Canonical SMILES |
CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)C=CC3=CC(=C(C=C3)OC)OC)C
|
|||||
InChI |
InChI=1S/C20H24N4O4/c1-6-23-18-17(19(25)24(7-2)20(23)26)22(3)16(21-18)11-9-13-8-10-14(27-4)15(12-13)28-5/h8-12H,6-7H2,1-5H3/b11-9+
|
|||||
InChIKey |
IQVRBWUUXZMOPW-PKNBQFBNSA-N
|
|||||
CAS Number |
CAS 155270-99-8
|
|||||
Pharmaceutical Properties | Molecular Weight | 384.4 | Topological Polar Surface Area | 76.9 | ||
Heavy Atom Count | 28 | Rotatable Bond Count | 6 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 5 | |||
XLogP |
2.5
|
|||||
PubChem CID | ||||||
PubChem SID |
103276933
, 104061724
, 11056223
, 114155109
, 12014869
, 126671671
, 134338968
, 134339069
, 134343014
, 135175557
, 135697573
, 137005694
, 140175846
, 144116113
, 14878146
, 152105687
, 152159601
, 152258274
, 152343827
, 160647112
, 162011669
, 162222240
, 163408039
, 163914047
, 164777218
, 170466116
, 172093763
, 172912718
, 174527720
, 175437836
, 178102242
, 179150002
, 185975314
, 198959942
, 206245955
, 208265417
, 223378751
, 223435458
, 223496120
, 223554827
, 223660299
, 223704923
, 39340766
, 47206484
, 50027674
, 50629398
, 57359333
, 7978842
, 85210094
, 92729739
|
|||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.